Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2012
05/31/2012WO2012030196A3 Oligonucleotide marker and method for identifying the same
05/31/2012WO2012027127A3 Elisa for haptoglobin-matrix metalloproteinase 9 complex as a diagnostic test for conditions including acute inflammation
05/31/2012WO2012021239A9 In vitro point-of-care sensor and method of use
05/31/2012WO2012021042A3 Method for crystallizing low mass ions for diagnosing colorectal cancer and method for diagnosing colorectal cancer using same
05/31/2012WO2012020985A3 Method for analyzing aspirin in plasma with liquid chromatography-mass spectrometry
05/31/2012WO2012018955A3 Cellular compositions and methods for their preparation and use
05/31/2012WO2012018609A3 Mig6 and therapeutic efficacy
05/31/2012WO2012016042A3 Glatiramer acetate molecular weight markers
05/31/2012WO2012008806A3 Method for screening for a tgase2 inhibitor or a tgase2 promoter using tgase2 and vhl
05/31/2012WO2012005588A3 Novel biomarkers for detecting neuronal loss
05/31/2012WO2012003334A3 Molecular probes for imaging of myelin
05/31/2012WO2011163497A3 Method for determining predisposition to esophageal-related disorders
05/31/2012WO2011162563A3 Disease marker detection kit and disease marker detection method
05/31/2012WO2011160048A3 Methods of identifying therapeutic agents for treating persister and bacterial infection
05/31/2012WO2011160043A3 Pla2g16 as a target for antiviral compounds
05/31/2012WO2011159537A3 Method and device for analyte detection
05/31/2012WO2011153234A3 Methods of inhibiting alu rna and therapeutic uses thereof
05/31/2012WO2011149272A3 Qualitative and quantitative analytical method for analyzing the activity type of an enzyme that is activated by proteolysis
05/31/2012WO2011146143A3 Enzymatic activity of psa as diagnostic marker for prostate cancer
05/31/2012WO2011146120A3 Assay for identifying antigens that activate b cell receptors comprising neutralizing antibodies
05/31/2012WO2011145908A3 Quantitative analysis method using a nanotube having integrated enzymes
05/31/2012WO2011133770A3 Salivary protein markers for detection of breast cancer
05/31/2012WO2011030217A3 Method for diagnosing multiple sclerosis
05/31/2012WO2011002856A3 Method for neutralization of antibiotics in a culture medium
05/31/2012US20120137378 Extraneous agents testing
05/31/2012US20120136588 Endoscope Integrity Tester Including Context-Sensitive Compensation and Methods of Context-Sensitive Integrity Testing
05/31/2012US20120136582 Measuring hematocrit and estimating hemoglobin values with a non-invasive, optical blood monitoring system
05/31/2012US20120136416 Caged Neuropeptides: modulation and measurement of synapse and signaling activity; and methods for drug evaluation, pharmaceuticals preparation and treatment
05/31/2012US20120136269 Liquid separation apparatus for removing a liquid from a respiratory gas and respiratory gas analyzing system
05/31/2012US20120136064 Methods for screening to identify therapeutic agents for alzheimer's disease and use thereof
05/31/2012US20120136057 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis
05/31/2012US20120136007 Methods and compositions for treating degenerative and ischemic disorders
05/31/2012US20120135983 DNA Damage Repair Inhibitors for the Treatment of Cancer
05/31/2012US20120135916 Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
05/31/2012US20120135892 siRNA targeting spleen tyrosine kinase
05/31/2012US20120135891 Methods and devices for early detection of cancer cells and types through micromechanical interactions
05/31/2012US20120135886 Method for detection of, or the risk of, bladder cancer
05/31/2012US20120135882 Methods for diagnosing chronic kidney disease and assessing the risk of disease progression
05/31/2012US20120135881 Markers for detection of gastric cancer
05/31/2012US20120135880 Crystal of Human Glycoprotein VI Collagen Binding Domain
05/31/2012US20120135879 Method and Composition for Cancer Diagnosis and Treatment
05/31/2012US20120135878 Generation of Neural Stem Cells from Human Trophoblast Stem Cells
05/31/2012US20120135875 Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
05/31/2012US20120135542 Methods and materials for diagnosing light chain amyloidosis
05/31/2012US20120135541 Multi-directional microfluidic devices comprising a pan-capture binding region and methods of using the same
05/31/2012US20120135540 Methods and compositions of nucleic acid ligands for detection of clinical analytes related to human health
05/31/2012US20120135539 Split DNA Enzyme for Visual Single Nucleotide Polymorphism Typing
05/31/2012US20120135538 Agent and method for identifying lysine crotonylation in proteins
05/31/2012US20120135532 Sensor Comprising Resrufin Levulinate Having Sulfite Ion Selectivity and Method for Monitoring Sulfite Ion Using the Same
05/31/2012US20120135531 Sensors for detecting substances indicative of stroke, ischemia, infection or inflammation
05/31/2012US20120135529 Detection of Occult Blood in Feces or Urine
05/31/2012US20120135527 Material, system, and method that provide indication of a breach
05/31/2012US20120135516 Artificial antibody polypeptides
05/31/2012US20120135508 System and method for analyte measurement
05/31/2012US20120135503 Minicell based delivery of biologically active compounds
05/31/2012US20120135450 Substrates, devices, and methods for quantitative liquid crystal assays
05/31/2012US20120135444 Sampling devices and methods of use
05/31/2012US20120135442 Protein crystallization using molecularly imprinted polymers
05/31/2012US20120135440 Cationic anti-microbial peptides and methods of use thereof
05/31/2012US20120135437 Biosensors utilizing ink jet-printed biomolecule compatible sol gel inks and uses thereof
05/31/2012US20120135435 Methods for Identifying Factors That Control the Folding of Amyloid Proteins of Diverse Origin
05/31/2012US20120135434 Mcpp immunoassay
05/31/2012US20120135433 Prognosis diagnosis method and prognosis diagnosis kit for sepsis or multiple organ failure
05/31/2012US20120135432 Diagnostic method for determining the susceptibility to delivery and reagent kit for use thereof
05/31/2012US20120135431 Type iv collagen-like immunoreactive peptide
05/31/2012US20120135430 Complement assays and uses thereof
05/31/2012US20120135429 Pro-grp as a surrogate marker to predict and monitor response to bcl-2 inhibitor therapy
05/31/2012US20120135428 Novel markers for chronic kidney disease
05/31/2012US20120135427 Methods for determining maternal health risks
05/31/2012US20120135426 Method for quantifying phosphokinase activity on proteins
05/31/2012US20120135425 ELISA for Haptoglobin-Matrix Metalloproteinase 9 Complex as a Diagnostic Test for Conditions Including Acute Inflammation
05/31/2012US20120135424 Mer diagnostic and therapeutic agents
05/31/2012US20120135423 Methods for GPCR signaling pathway determination using biosensor-cell assays
05/31/2012US20120135422 Anti-gpcr antibody and the method of producing the same
05/31/2012US20120135421 Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins
05/31/2012US20120135420 Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof
05/31/2012US20120135419 Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic Leukemia and Oligonucleotides for Use in this Method
05/31/2012US20120135418 Automatic Detection Kit for Detecting HLA Alleles Using Real-Time Polymerase Chain Reaction
05/31/2012US20120135415 Detecting cancer with anti-cxcl13 and anti-cxcr5 antibodies
05/31/2012US20120135412 Quality control bioassays for nutriceutical and medicinal products
05/31/2012US20120135408 Unc-45a splice variants based cancer diagnostics and therapeutics
05/31/2012US20120135401 Methods and Compounds for the Diagnosis of Inflammatory Disease and Identification of Pharmacological Agents Useful in the Treatment of Inflammatory Disease
05/31/2012US20120135399 Cancer biomarker and methods of using thereof
05/31/2012US20120135398 Method of Detection and Related Detection Device
05/31/2012US20120135396 Multi-Shell Microspheres With Integrated Chromatographic And Detection Layers For Use In Array Sensors
05/31/2012US20120135064 Conjugated nanodelivery vehicles
05/31/2012US20120135027 Proteins used for the diagnosis of lyme borreliosis
05/31/2012US20120135024 Neisseria meningitidis antigens and compositions
05/31/2012US20120135018 Erg monoclonal antibodies
05/31/2012US20120135009 Cleaved and Phosphorylated CRMP2 as Blood Marker of Inflammatory Diseases of the Central Nervous System
05/31/2012US20120135008 Methods and compositions for targeting polyubiquitin
05/31/2012US20120135004 Antibodies to matrix metalloproteinase 9
05/31/2012US20120135003 Anti-ilt7 antibody
05/31/2012US20120135000 Methods and compositions for treating ocular disorders
05/31/2012US20120134999 PORIN B (PorB) AS A THERAPEUTIC TARGET FOR PREVENTION AND TREATMENT OF INFECTION BY CHLAMYDIA
05/31/2012US20120134998 Secreted ap2 and methods of inhibiting same
05/31/2012US20120134997 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
05/31/2012US20120134985 Methods for modulating metabolic and circadian rhythms
05/31/2012US20120134969 Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
05/31/2012US20120134929 Treatment of macrophage-related disorders
1 ... 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 ... 3937